Shanghai Pharmaceuticals Holding Co., Ltd

Símbolo: SHPMF

PNK

1.21

USD

Preço de mercado atual

  • 10.5395

    Rácio P/E

  • -0.1533

    Rácio PEG

  • 6.25B

    Capitalização da MRK

  • 0.01%

    Rendimento DIV

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Demonstrações financeiras

No gráfico, pode ver os números predefinidos em dinâmica para Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF). A receita da empresa mostra a média de NaN M que é o crescimento de NaN %. O lucro bruto médio para todo o período é NaN M que é NaN %. O rácio médio da margem bruta é NaN %. O crescimento do rendimento líquido para o desempenho da empresa no último ano é NaN % que é igual a NaN % % em média para todo o historial da empresa.,

Balanço

Mergulhando na trajetória fiscal da Shanghai Pharmaceuticals Holding Co., Ltd, observamos um crescimento médio dos ativos. Essa taxa, curiosamente, está em , refletindo os altos e baixos da empresa. Quando comparado trimestre a trimestre, esse número se ajusta a . Uma retrospectiva do ano passado revela uma mudança total de ativos de NaN. O valor dos accionistas, representado pelo total do capital próprio, é avaliado em NaN na moeda de reporte. A variação anual deste aspeto é NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

040669.93701522390.4
22296.2
18152.8
18694.7
14842.7
11970.9
12039.8
11608.6
12978.8
13528.3
14852.7
6341.6
1229.2
1046.4
665.2
564
430.1
522.7
555.3
675.2
587.3
699.2
435.7
258.9
63.2
36.2
30.6
0

balance-sheet.row.short-term-investments

010152.29613.6-1242.8
-1226.3
-1362.9
-1434.9
0.6
4.1
0.8
0.5
0.3
2.9
2.7
3.2
7.3
9.2
35.8
62.5
115.9
92.3
43.1
3.1
50.6
100
0.7
0
0
0
0
0

balance-sheet.row.net-receivables

083736.47663465885.8
59921.7
53944.4
48324.7
35415.5
30982.1
27895.5
23605.7
18170.1
15008.5
12701.1
9322.2
3419.6
2853.3
2751.2
2582.3
2539.6
3002.4
2474.6
1923.1
1615.8
53.1
98.9
92.1
30.2
13.7
19.7
0

balance-sheet.row.inventory

036623.434460.227104
24088.3
24877.4
25024
17270
16415.8
15090.6
13088.2
10996.5
9809.7
8297.5
5040.7
1974.5
1622.8
1364.2
1191.4
1351.1
1223
1370.2
1170
824
610.9
571.3
608.5
125.3
99
73
0

balance-sheet.row.other-current-assets

01404.21403.71114.2
1256.7
1117
1234.5
1114.1
898.2
559.3
355.9
369.6
455.4
144.5
2.7
-121.4
0.1
0.1
15.3
21.5
2.5
0
0
0.3
1329.2
1201.6
1068.6
120.2
95.5
86.4
189.1

balance-sheet.row.total-current-assets

0162433.9149512.9116494.4
107562.9
98091.6
93277.9
68642.3
60266.9
55585.2
48658.3
42515
38801.9
35995.8
20707.2
6502
5522.6
4780.7
4353
4342.2
4750.5
4400.2
3768.3
3027.5
2692.4
2307.5
2028
339
244.4
209.7
189.1

balance-sheet.row.property-plant-equipment-net

01787316185.315390.7
14220.6
12717.7
10194.6
8691.6
6561.1
5693.4
4993.7
4808.9
4259.4
4039.6
3978.5
892.4
913.5
1129.5
1184.6
979.6
1033.1
1077.1
1058.1
698.4
577.2
511.2
420
217.7
223.6
203
222.3

balance-sheet.row.goodwill

011393.311335.911239
11342.3
10789.9
11345.3
6606.7
5848
4815.6
4473.4
3643.3
3172.8
2988.9
422.8
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

06361.36586.76308.7
5419.1
4142
4283.2
2702.4
2767.1
1984.2
1861.6
1540.3
1406.7
1276.2
875.9
432.5
446.6
526.2
366.1
73.7
143.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.goodwill-and-intangible-assets

017754.717922.717547.6
16761.3
14931.9
15628.5
9309.1
8615.1
6799.8
6335
5183.6
4579.5
4265.1
1298.7
432.5
446.6
526.2
366.1
73.7
146.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.long-term-investments

0450.51863.611778.3
8888.9
6795.3
6083.4
4802.6
4492.5
3914.6
2932.5
2845.9
2691.4
2634.7
1597.4
277.7
330.2
299.6
701.1
846.5
393.5
404.8
330.4
295.6
36.6
125.2
0
0
0
0
0

balance-sheet.row.tax-assets

01716.91534.71367.5
1359.4
1222.5
1037.9
566.3
468.3
316.3
264.6
199.8
191.7
178.6
150.2
80.3
47.4
29.1
0
0
0
86.6
50.6
88
3.1
-111.6
0
0
0
0
0

balance-sheet.row.other-non-current-assets

011743.611115.7856.9
392.5
3267.5
657.1
2332.6
2338.8
2035
1156.4
758.3
544.9
554
437
944.1
990.4
720.9
73.7
134.1
140.1
86.6
50.6
88
144.4
20.7
66.5
35.6
33.8
36.8
10.3

balance-sheet.row.total-non-current-assets

049538.74862246941.1
41622.7
38934.8
33601.5
25702.2
22475.8
18759
15682.2
13796.5
12267.1
11672
7461.8
2155
2232.9
2344.9
2325.5
2033.8
1713.6
1754.7
1634.5
1265.7
842.9
748.2
583.2
253.6
257.6
240.2
232.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.account-payables

054632.551565.541995.4
37792.2
36872.5
35148
27295.2
25985.1
24436.9
20435.9
16875.8
14574.9
12659.5
8667.7
3974.2
3096
2689.7
2061.8
1650.6
1823.1
1534.1
1377.1
965.8
687.8
698.9
718.7
62.2
56.8
36.6
0

balance-sheet.row.short-term-debt

0385243100023096.6
29107.2
24327.3
22038.7
13803.5
9646.7
10679.3
7953.1
5924.4
4900.8
5675.5
4818.4
1691.1
1919.5
1999.5
2148.3
2309.9
2057.2
1897.7
1511
1131.2
1578
1308.8
984
195.8
188.3
103.1
0

balance-sheet.row.tax-payables

01217.21440.81692.7
1478.1
1215.4
1042.2
1141.4
642.5
612
546.5
393.6
415.9
393.1
254.3
56.8
29
-0.4
19.3
-49.8
-22.7
-16.1
-14.5
6.2
-4.5
-5.7
-10.8
11.5
3.9
0.4
0

balance-sheet.row.long-term-debt-total

07336.27561.48592
2685.1
10289.9
9620.3
2958.8
2836.3
93.4
105.4
125.2
40.8
52.3
66.1
22.1
25.1
3
1.2
103.2
102.1
89.7
30.8
17.5
2.6
1.6
15.6
21.5
33.7
100.7
0

Deferred Revenue Non Current

0633.5534.62349.1
2224.1
1278.7
503.3
495.8
589.7
367.9
554.3
0.5
0.5
160.4
156.9
28.1
30.4
32.3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

06291.96384.99232.4
5018.6
1188.6
2698.4
8533.1
5481.5
4310.4
3613.5
2898.7
2622.4
2521
2431.5
592.8
566.1
437.4
377.7
283.1
392.4
463
444.3
316.3
293.5
196.8
172.8
27.4
34.2
26.4
130.9

balance-sheet.row.total-non-current-liabilities

09274.69441.412545
6311.9
13032.8
11736.3
5036.8
4794.9
1109.6
1238.9
1611.6
1270.1
830.4
367.2
76.4
84.1
40.8
23.8
126.6
130.4
132.6
70.8
61.6
-9.3
1.2
22.3
21.5
33.7
100.7
94.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01550.11301.61434.3
1501
1155.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0131646.4120132.5104369.3
94444.9
87640.5
80446.1
54668.6
45908.3
40536.2
33241.4
27310.5
23368.2
21686.4
16284.8
6334.6
5665.8
5167.3
4611.7
4370.2
4403.1
4027.4
3403.2
2474.9
2550
2205.7
1897.8
306.9
313
266.9
225.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

03703.33697.52842.1
2842.1
2842.1
2842.1
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
1992.6
569.2
569.2
569.2
474.3
474.3
474.3
474.3
316.2
316.2
229.6
229.6
153
113
58
58
58

balance-sheet.row.retained-earnings

033822.332479.928598.6
25054.4
21970.9
19330.6
16578.3
14138.4
11961
10009.3
8252.6
6718.3
5196.3
3117
437.3
304.1
263
301.1
279
286.7
282.1
168.9
154.9
123.3
32.5
64.9
17.3
0.1
0
16.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

01532.11553.91565.1
1152.1
531.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

029466.429331.716353.7
16306.2
16315
16840.8
14763.6
14795.2
15280.4
15123.9
15012.3
15232.1
15193.3
4024.9
827.1
815.8
809.2
980
1004.3
1002.2
973.4
1074.5
1034.2
441.2
365.8
380.1
155.2
131
125
122.2

balance-sheet.row.total-stockholders-equity

068524.16706349359.5
45354.7
41659.1
39013.6
34030.8
31622.6
29930.3
27822.1
25953.8
24639.3
23078.5
9134.6
1833.5
1689.1
1641.4
1755.5
1757.6
1763.3
1729.8
1559.6
1505.3
794
627.8
598
285.6
189.1
183
196.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.minority-interest

011801.910939.49706.7
9386.1
7726.9
7419.7
5645
5211.9
3877.7
3277
3047.2
3061.6
2903
2749.7
488.9
400.7
316.9
311.5
248.3
297.8
397.7
440
312.9
191.3
222.1
115.5
0
0
0
0

balance-sheet.row.total-equity

080326.178002.559066.2
54740.7
49385.9
46433.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

010602.711477.210535.6
7662.7
5432.4
4648.6
4803.2
4496.6
3915.4
2933
2846.2
2694.4
2637.3
1600.6
285
339.3
335.5
763.6
962.4
485.8
448
333.5
346.2
136.6
125.9
55.6
0.4
0.4
0.9
0

balance-sheet.row.total-debt

045860.238561.431688.6
31792.3
34617.1
31659
16762.3
12483
10772.7
8058.5
6049.6
4941.5
5727.8
4884.5
1713.2
1944.6
2002.4
2149.6
2413.2
2159.3
1987.3
1541.9
1148.6
1580.5
1310.4
999.6
217.3
222
203.8
0

balance-sheet.row.net-debt

015342.5111609298.3
9496.1
16464.3
12964.3
1920.2
516.2
-1266.3
-3549.5
-6928.9
-8583.9
-9122.3
-1453.9
491.3
907.4
1373
1648.1
2099
1728.9
1475.1
869.8
611.9
981.3
875.4
740.7
154.2
185.8
173.2
0

Demonstração dos fluxos de caixa

O panorama financeiro da Shanghai Pharmaceuticals Holding Co., Ltd registou uma alteração notável no fluxo de caixa livre durante o último período, apresentando uma mudança de NaN. A empresa aumentou recentemente o seu capital social através da emissão de NaN, marcando uma diferença de NaN em relação ao ano anterior. As actividades de investimento da empresa resultaram numa utilização líquida de tesouraria, no montante de NaN na moeda de relato. Trata-se de uma mudança de NaN em relação ao ano anterior. No mesmo período, A empresa registou NaN, NaN e NaN, que são significativos para compreender as estratégias de investimento e reembolso da empresa. As actividades de financiamento da empresa conduziram a uma utilização líquida de caixa de NaN, com uma diferença ano após ano de NaN. Além disso, a empresa atribuiu NaN para pagamento de dividendos aos seus accionistas. Ao mesmo tempo, envolveu-se noutras manobras financeiras, referidas como NaN, que também tiveram um impacto significativo no seu fluxo de caixa durante este período. Estes componentes, em conjunto, dão uma imagem abrangente da situação financeira da empresa e da abordagem estratégica relativamente à gestão do fluxo de caixa.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

05166.669926274.6
5605.3
4830.7
4456.3
4057.8
3829.7
3364.4
2992
2626.6
2460.6
2446
1779
263.5
129.4
95.5
90.5
71.4
138.5
207.5
163.1
174.8
204.7
110.8
89.8

cash-flows.row.depreciation-and-amortization

02187.12222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4

cash-flows.row.deferred-income-tax

0-194.8-131.9165
-233.9
-217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0194.8131.9-165
233.9
217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-4345.5-4680-3398.7
-2013.7
-2571
-3711.7
-2291.7
-2635.8
-2747.8
-2234.2
-2275.2
-2026.7
-942.8
-368.4
62.9
-104
109.2
298.3
-148.2
-242.3
-230.7
-231
-171.1
-101.2
-61.8
-464.7

cash-flows.row.account-receivables

0-6432.4-10081.4-6155.5
-4072.2
-5083.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2303.8-7111.7-3201
932.6
63.1
-2842.9
-423
-942.7
-1943.7
-1587
-1179.7
-1466.4
-1565.9
-859.2
-323.3
-270.1
-12.3
153.4
-158.7
71.3
-300
-209.9
-206.2
-39.7
75.8
-509.9

cash-flows.row.account-payables

04585.5126455792.8
1359.7
2667.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-194.8-131.9165
-233.9
-217.7
-868.8
-1868.8
-1693.1
-804.2
-647.3
-1095.4
-560.3
623.1
490.8
386.2
166.1
121.5
144.9
10.5
-313.6
69.3
-21.1
35.1
-61.5
-137.6
45.1

cash-flows.row.other-non-cash-items

02223.3208.945.6
1115.4
1877.7
1221.1
42.8
6.7
60.1
-7.1
72.3
180.3
-210
-107.2
244.6
166.1
187.8
125.1
90.7
91.2
-46.6
96.5
11.7
-7.4
72.2
70.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.acquisitions-net

0-356.622.5-1039.3
-2045.7
-693.7
-5197.5
-913.6
-1738.7
-602.7
-1083.2
-455.3
-414.2
-4017.5
-2001.5
4
111.2
20.7
218.2
270.2
341.7
176.7
56.5
157.5
142.3
0.2
0

cash-flows.row.purchases-of-investments

0-27376.7-39683.8-3147.8
-4490.9
-1041.4
-1047.6
-4461.3
-2600.6
-1887.9
-707.9
35.8
20.1
41.6
-1325.4
-6.3
-23.2
-13
-22.6
-159.4
-190.1
-344.6
-78.7
-405
-102.3
-175.8
-31.2

cash-flows.row.sales-maturities-of-investments

027861.4302673288.2
4806.1
1271.6
1331.8
5119.4
3099.4
2055.4
976.9
251
179.6
476.3
430.4
36.3
62.1
22.5
108.9
10.3
122.9
102.5
75.4
334.2
122.2
2.1
4.9

cash-flows.row.other-investing-activites

0350.6-394-997.8
3034.8
-1367.7
-836.4
-92.2
469.7
246.6
261.1
216.5
542.3
164.3
703.8
3.9
290.2
9.2
66.6
72.1
87.3
7.1
182.9
12.8
1.2
0.3
-0.1

cash-flows.row.net-cash-used-for-investing-activites

0-2491.9-12473.1-6015.6
-1705.7
-4584.3
-7692.7
-2355
-2889.5
-1908.9
-1844.6
-892.8
-401.3
-3790.4
-2743
-46.1
349.8
-173.6
1.3
-275
-234.2
-404.6
-99.8
-202.7
-120
-225.8
-196.2

cash-flows.row.debt-repayment

0-72338.3-59808.7-52214.6
-47575.5
-38340.3
-53206.6
-22044.2
-18181.3
-18367.5
-13253.9
-10475.4
-8897.8
-12753.3
-5212.4
-3352.6
-3656.8
-3091.2
-4245.5
-3786.5
-3967.5
-204.2
-289.3
-2536.2
-1871.5
-1822.2
-1445.9

cash-flows.row.common-stock-issued

0000
0
0
2624.8
21.8
905.6
301.4
17.2
35.5
55.1
0
2046.4
6.9
24.3
0
0
0
7.2
0.9
4.5
606.4
0
0
263.2

cash-flows.row.common-stock-repurchased

0000
0
0
60659.6
25613.7
18697.4
19978.7
14169.7
11301.7
7764.4
0
4038.1
3061.5
3581.5
0
0
0
4170.7
595
537.4
1427.5
0
0
1703.9

cash-flows.row.dividends-paid

0-3981.2-3093.9-2675.9
-2418.4
-2584.2
-2357.8
-1750.2
-1443.5
-1378.2
-1251.6
-1055.4
-891.2
-775.3
-545.6
-136.7
-196
-141.8
-139.2
-210.2
-128.4
-148.3
-122.9
-49.7
-126.5
-50.4
-73

cash-flows.row.other-financing-activites

076551.475041.256456.1
48732.6
38598.7
-193.7
26087.3
19366.6
20080.6
13539.5
10773.8
7707.9
24171.7
6037.1
3092.2
3556.4
2897.7
3985.6
4084.9
4177.8
595.9
541.9
2053.9
2135.9
2110.2
1935.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0231.912138.61565.6
-1261.2
-2325.8
7526.3
2314.7
647.4
636.4
-948.8
-721.6
-2026
10643.1
2325.4
-390.3
-272.1
-335.3
-399.1
88.3
89.1
244.3
134.2
74.5
137.9
237.5
680

cash-flows.row.effect-of-forex-changes-on-cash

0-5.6-12.4-50.3
-17.6
-1.6
67.4
-18.8
-2.6
10.7
2.8
-14.6
22.7
-280.8
-5.5
0.5
1.4
-1.5
2
-2.5
1.7
0
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

02965.94396.4561.1
3860.2
-889.3
3036.1
2589.7
-298.1
87.4
-1454.9
-655.5
-1253.8
8344.3
1263.1
228.2
364.9
-21.5
187.3
-116.2
-81.7
-159.9
135.3
-62.5
164.2
176.1
200.6

cash-flows.row.cash-at-end-of-period

027499.824533.920137.5
19576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6039.6
1197.7
969.5
607.2
501.5
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9

cash-flows.row.cash-at-beginning-of-period

024533.920137.519576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6210.4
4776.5
969.5
604.7
628.7
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9
58.2

cash-flows.row.operating-cash-flow

05231.54743.45061.3
6844.7
6022.4
3135.1
2648.8
1946.7
1349.2
1335.7
973.4
1150.8
1772.4
1686.1
664.1
285.7
488.9
583.1
73
61.7
0.5
100.8
65.7
146.2
164.7
-283.1

cash-flows.row.capital-expenditure

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.free-cash-flow

02260.92058.5942.6
3834.7
3269.3
1192.1
641.5
-172.6
-371.3
44.2
68.4
441.9
1358.9
1135.8
584.2
195.2
296.7
431.5
-125.1
-192.7
-169.1
-178.6
-79
5.1
112.2
-453

Linha de demonstração de resultados

A receita da Shanghai Pharmaceuticals Holding Co., Ltd registou uma variação de NaN% em comparação com o período anterior. O lucro bruto de SHPMF é reportado como NaN. As despesas operacionais da empresa são NaN, apresentando uma variação de NaN% em relação ao ano anterior. As despesas de depreciação e amortização são NaN, o que representa uma variação de NaN% em relação ao último período contabilístico. As despesas operacionais são reportadas como NaN, o que mostra uma variação anual de NaN%. As despesas de vendas e marketing são NaN, o que representa uma variação de NaN% em relação ao ano anterior. O EBITDA baseado nos números recentes é de NaN, representando um crescimento de NaN% em relação ao ano anterior. O rendimento operacional é NaN, que apresenta uma variação de NaN% em comparação com o ano anterior. A variação no rendimento líquido é de NaN%. O rendimento líquido do último ano foi de NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

0260295.1231981.3215824.3
191909.2
186565.8
159084.4
130847.2
120764.7
105516.6
92398.9
78222.8
68078.1
54899.9
37411.1
19568.1
16547.8
13919.8
11410.3
10699.3
10815
9785.8
7235.7
5202
4595.3
4529.9
4413.4
339.8
321
337.4
241.3
225.7

income-statement-row.row.cost-of-revenue

0228966.9201494.9187281.1
164474
159751.7
136521.5
114122.7
106530.9
92715.3
80994.1
67980.1
58792.6
46882.2
30619.9
17851.8
15101.4
12697.8
10618.3
9997.3
9794
8774.9
6215.3
4491.7
4003.8
3970
3886.7
291.8
270.4
291.9
205.8
193.8

income-statement-row.row.gross-profit

031328.130486.428543.1
27435.2
26814.1
22562.9
16724.5
14233.8
12801.3
11404.8
10242.7
9285.5
8017.7
6791.1
1716.3
1446.4
1222
792
702
1020.9
1010.9
1020.3
710.3
591.5
559.9
526.7
48
50.6
45.5
35.4
31.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-612.912.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.operating-expenses

02176321705.420616.2
19297.4
18884.5
16326.3
11747
9972.3
8846.1
8010.4
7341
6617.6
5584.3
4909.4
1112.4
1095.3
956.4
630
632
925.2
850.3
843.1
544.3
413.1
379.3
380.5
20.4
20.8
15.6
9.1
6.6

income-statement-row.row.cost-and-expenses

0250729.9223200.3207897.3
183771.4
178636.2
152847.7
125869.7
116503.2
101561.4
89004.5
75321.1
65410.2
52466.5
35529.4
18964.2
16196.7
13654.2
11248.2
10629.3
10719.2
9625.1
7058.5
5036
4416.9
4349.3
4267.2
312.2
291.2
307.5
214.9
200.4

income-statement-row.row.interest-income

0-461.8438.3338.2
288.3
234
197.4
161.4
172
138
207
242.1
304.4
262.9
47.2
10.6
8.4
20.8
18.5
19.7
23.4
15.5
7.8
8.2
17.6
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-612.9-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-612.912.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.total-operating-expenses

0-612.9-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.depreciation-and-amortization

02187.12222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4
-3
11.7
8.5
3.3
1.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

07667.29014.78205.5
7184.4
6213.9
5208.3
5228.2
4207.1
3686.6
3269.5
3074.3
2795.9
2873.7
2076.6
370.7
163.6
122.6
84.6
61.2
150.1
219.5
191.6
203.3
218.4
137.5
89.9
30.6
18.1
21.4
23
23.7

income-statement-row.row.income-before-tax

07054.38808.48143.8
7175.5
6262.5
5343.4
5204.8
4639
4171.9
3799.7
3260.8
3087.7
3035.1
2172.5
355
186.7
146.6
101.5
98.7
190.8
257.9
213.5
202.3
222.3
137.9
109.6
29.7
17.9
21.6
24.2
23.4

income-statement-row.row.income-tax-expense

01887.71816.31869.2
1570.2
1431.7
887.1
1147
809.3
807.5
807.7
634.2
627.1
589.1
393.6
91.5
57.3
51.1
40.3
25.9
52.3
50.4
50.3
27.6
17.6
27.1
19.8
1
2.6
3.2
3.6
3.6

income-statement-row.row.net-income

037685617.25093.5
4496.2
4081
3881.1
3520.6
3196.4
2877
2591.1
2242.9
2052.9
2042.2
1368.3
173.3
82
66.3
68.7
50.5
93.1
154.4
125.8
145.3
184.8
94.4
78.7
28.7
15.2
18.3
20.6
19.9

Perguntas frequentes

O que é Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) total assets?

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) o total de activos é 211972533766.000.

Qual é a receita anual da empresa?

A receita anual é N/A.

Qual é a margem de lucro da empresa?

A margem de lucro da empresa é 0.116.

Qual é o fluxo de caixa livre da empresa?

O fluxo de caixa livre é -0.102.

Qual é a margem de lucro líquido da empresa?

A margem de lucro líquido é 0.014.

Qual é a receita total da empresa?

A receita total é 0.029.

O que é Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) lucro líquido (lucro líquido)?

O lucro líquido (rendimento líquido) é 3767999581.000.

Qual é a dívida total da empresa?

A dívida total é 45860206958.000.

Qual é o número de despesas operacionais?

As despesas operacionais são 21762997476.000.

Qual é o valor de caixa da empresa?

O dinheiro da empresa é 0.000.